COVID-19 Outbreak-Global Genetic Engineering Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- MAI4050237
- 111 Pages
- September 2020
- BFSI
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Genetic Engineering Drug industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Genetic Engineering Drug market can be split based on product types, major applications, and important countries as follows:
Key players in the global Genetic Engineering Drug market covered in Chapter 12:
Tonghua Dongbao Pharmaceutical Co., Ltd
Beijing SL Pharmaceutical Co., Ltd
Anhui Anke Biotechnology (Group) Co., Ltd
Jiangsu Sihuan Bioengineering Co., Ltd
Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
3SBio Inc.
GeneScience Pharmaceuticals Co., Ltd
Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
Biotech Pharmaceutical Co., Ltd
In Chapter 4 and 14.1, on the basis of types, the Genetic Engineering Drug market from 2015 to 2025 is primarily split into:
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
In Chapter 5 and 14.2, on the basis of applications, the Genetic Engineering Drug market from 2015 to 2025 covers:
＜30 Years Old
30 Years Old-60 Years Old
＞60 Years Old
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Genetic Engineering Drug Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Genetic Engineering Drug
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Genetic Engineering Drug industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Genetic Engineering Drug Market Size, 2015 – 2020
2.1.2 Global Genetic Engineering Drug Market Size by Type, 2015 – 2020
2.1.3 Global Genetic Engineering Drug Market Size by Application, 2015 – 2020
2.1.4 Global Genetic Engineering Drug Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Genetic Engineering Drug Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Genetic Engineering Drug Analysis
3.2 Major Players of Genetic Engineering Drug
3.3 Genetic Engineering Drug Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Genetic Engineering Drug
3.3.3 Labor Cost of Genetic Engineering Drug
3.4 Market Distributors of Genetic Engineering Drug
3.5 Major Downstream Buyers of Genetic Engineering Drug Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Genetic Engineering Drug Market, by Type
4.1 Global Genetic Engineering Drug Value and Market Share by Type (2015-2020)
4.2 Global Genetic Engineering Drug Production and Market Share by Type (2015-2020)
4.3 Global Genetic Engineering Drug Value and Growth Rate by Type (2015-2020)
4.3.1 Global Genetic Engineering Drug Value and Growth Rate of Monoclonal Antibody
4.3.2 Global Genetic Engineering Drug Value and Growth Rate of Recombinant Human Erythropoietin
4.3.3 Global Genetic Engineering Drug Value and Growth Rate of Recombinant Human Interferon
4.3.4 Global Genetic Engineering Drug Value and Growth Rate of Recombinant Human Growth Hormone
4.3.5 Global Genetic Engineering Drug Value and Growth Rate of Recombinant Human Insulin
4.4 Global Genetic Engineering Drug Price Analysis by Type (2015-2020)
5 Genetic Engineering Drug Market, by Application
5.1 Downstream Market Overview
5.2 Global Genetic Engineering Drug Consumption and Market Share by Application (2015-2020)
5.3 Global Genetic Engineering Drug Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Genetic Engineering Drug Consumption and Growth Rate of ＜30 Years Old (2015-2020)
5.3.2 Global Genetic Engineering Drug Consumption and Growth Rate of 30 Years Old-60 Years Old (2015-2020)
5.3.3 Global Genetic Engineering Drug Consumption and Growth Rate of ＞60 Years Old (2015-2020)
6 Global Genetic Engineering Drug Market Analysis by Regions
6.1 Global Genetic Engineering Drug Sales, Revenue and Market Share by Regions
6.1.1 Global Genetic Engineering Drug Sales by Regions (2015-2020)
6.1.2 Global Genetic Engineering Drug Revenue by Regions (2015-2020)
6.2 North America Genetic Engineering Drug Sales and Growth Rate (2015-2020)
6.3 Europe Genetic Engineering Drug Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Genetic Engineering Drug Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Genetic Engineering Drug Sales and Growth Rate (2015-2020)
6.6 South America Genetic Engineering Drug Sales and Growth Rate (2015-2020)
7 North America Genetic Engineering Drug Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Genetic Engineering Drug Sales, Revenue and Market Share by Countries
7.2.1 North America Genetic Engineering Drug Sales by Countries (2015-2020)
7.2.2 North America Genetic Engineering Drug Revenue by Countries (2015-2020)
7.3 United States Genetic Engineering Drug Sales and Growth Rate (2015-2020)
7.4 Canada Genetic Engineering Drug Sales and Growth Rate (2015-2020)
7.5 Mexico Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8 Europe Genetic Engineering Drug Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Genetic Engineering Drug Sales, Revenue and Market Share by Countries
8.2.1 Europe Genetic Engineering Drug Sales by Countries (2015-2020)
8.2.2 Europe Genetic Engineering Drug Revenue by Countries (2015-2020)
8.3 Germany Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8.4 UK Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8.5 France Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8.6 Italy Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8.7 Spain Genetic Engineering Drug Sales and Growth Rate (2015-2020)
8.8 Russia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9 Asia Pacific Genetic Engineering Drug Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Genetic Engineering Drug Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Genetic Engineering Drug Sales by Countries (2015-2020)
9.2.2 Asia Pacific Genetic Engineering Drug Revenue by Countries (2015-2020)
9.3 China Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9.4 Japan Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9.5 South Korea Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9.6 India Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
9.8 Australia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
10 Middle East and Africa Genetic Engineering Drug Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Genetic Engineering Drug Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Genetic Engineering Drug Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Genetic Engineering Drug Revenue by Countries (2015-2020)
10.3 Saudi Arabia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
10.4 UAE Genetic Engineering Drug Sales and Growth Rate (2015-2020)
10.5 Egypt Genetic Engineering Drug Sales and Growth Rate (2015-2020)
10.6 Nigeria Genetic Engineering Drug Sales and Growth Rate (2015-2020)
10.7 South Africa Genetic Engineering Drug Sales and Growth Rate (2015-2020)
11 South America Genetic Engineering Drug Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Genetic Engineering Drug Sales, Revenue and Market Share by Countries
11.2.1 South America Genetic Engineering Drug Sales by Countries (2015-2020)
11.2.2 South America Genetic Engineering Drug Revenue by Countries (2015-2020)
11.3 Brazil Genetic Engineering Drug Sales and Growth Rate (2015-2020)
11.4 Argentina Genetic Engineering Drug Sales and Growth Rate (2015-2020)
11.5 Columbia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
11.6 Chile Genetic Engineering Drug Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Tonghua Dongbao Pharmaceutical Co., Ltd
12.1.1 Tonghua Dongbao Pharmaceutical Co., Ltd Basic Information
12.1.2 Genetic Engineering Drug Product Introduction
12.1.3 Tonghua Dongbao Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.2 Beijing SL Pharmaceutical Co., Ltd
12.2.1 Beijing SL Pharmaceutical Co., Ltd Basic Information
12.2.2 Genetic Engineering Drug Product Introduction
12.2.3 Beijing SL Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.3 Anhui Anke Biotechnology (Group) Co., Ltd
12.3.1 Anhui Anke Biotechnology (Group) Co., Ltd Basic Information
12.3.2 Genetic Engineering Drug Product Introduction
12.3.3 Anhui Anke Biotechnology (Group) Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.4 Jiangsu Sihuan Bioengineering Co., Ltd
12.4.1 Jiangsu Sihuan Bioengineering Co., Ltd Basic Information
12.4.2 Genetic Engineering Drug Product Introduction
12.4.3 Jiangsu Sihuan Bioengineering Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.5 Shanghai Lansheng Guojian Pharmaceutical Co., Ltd
12.5.1 Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Basic Information
12.5.2 Genetic Engineering Drug Product Introduction
12.5.3 Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.6 3SBio Inc.
12.6.1 3SBio Inc. Basic Information
12.6.2 Genetic Engineering Drug Product Introduction
12.6.3 3SBio Inc. Production, Value, Price, Gross Margin 2015-2020
12.7 GeneScience Pharmaceuticals Co., Ltd
12.7.1 GeneScience Pharmaceuticals Co., Ltd Basic Information
12.7.2 Genetic Engineering Drug Product Introduction
12.7.3 GeneScience Pharmaceuticals Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.8 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd
12.8.1 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Basic Information
12.8.2 Genetic Engineering Drug Product Introduction
12.8.3 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Production, Value, Price, Gross Margin 2015-2020
12.9 Biotech Pharmaceutical Co., Ltd
12.9.1 Biotech Pharmaceutical Co., Ltd Basic Information
12.9.2 Genetic Engineering Drug Product Introduction
12.9.3 Biotech Pharmaceutical Co., Ltd Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Genetic Engineering Drug Market Forecast
14.1 Global Genetic Engineering Drug Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Monoclonal Antibody Market Value and Volume Forecast (2020-2025)
14.1.2 Recombinant Human Erythropoietin Market Value and Volume Forecast (2020-2025)
14.1.3 Recombinant Human Interferon Market Value and Volume Forecast (2020-2025)
14.1.4 Recombinant Human Growth Hormone Market Value and Volume Forecast (2020-2025)
14.1.5 Recombinant Human Insulin Market Value and Volume Forecast (2020-2025)
14.2 Global Genetic Engineering Drug Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 ＜30 Years Old Market Value and Volume Forecast (2020-2025)
14.2.2 30 Years Old-60 Years Old Market Value and Volume Forecast (2020-2025)
14.2.3 ＞60 Years Old Market Value and Volume Forecast (2020-2025)
14.3 Genetic Engineering Drug Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Genetic Engineering Drug
Table Product Specification of Genetic Engineering Drug
Table Genetic Engineering Drug Key Market Segments
Table Key Players Genetic Engineering Drug Covered
Figure Global Genetic Engineering Drug Market Size, 2015 – 2025
Table Different Types of Genetic Engineering Drug
Figure Global Genetic Engineering Drug Value ($) Segment by Type from 2015-2020
Figure Global Genetic Engineering Drug Market Share by Types in 2019
Table Different Applications of Genetic Engineering Drug
Figure Global Genetic Engineering Drug Value ($) Segment by Applications from 2015-2020
Figure Global Genetic Engineering Drug Market Share by Applications in 2019
Figure Global Genetic Engineering Drug Market Share by Regions in 2019
Figure North America Genetic Engineering Drug Production Value ($) and Growth Rate (2015-2020)
Figure Europe Genetic Engineering Drug Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Genetic Engineering Drug Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Genetic Engineering Drug Production Value ($) and Growth Rate (2015-2020)
Figure South America Genetic Engineering Drug Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Genetic Engineering Drug
Table Upstream Raw Material Suppliers of Genetic Engineering Drug with Contact Information
Table Major Players Headquarters, and Service Area of Genetic Engineering Drug
Figure Major Players Production Value Market Share of Genetic Engineering Drug in 2019
Table Major Players Genetic Engineering Drug Product Types in 2019
Figure Production Process of Genetic Engineering Drug
Figure Manufacturing Cost Structure of Genetic Engineering Drug
Figure Channel Status of Genetic Engineering Drug
Table Major Distributors of Genetic Engineering Drug with Contact Information
Table Major Downstream Buyers of Genetic Engineering Drug with Contact Information
Table Global Genetic Engineering Drug Value ($) by Type (2015-2020)
Table Global Genetic Engineering Drug Value Share by Type (2015-2020)
Figure Global Genetic Engineering Drug Value Share by Type (2015-2020)
Table Global Genetic Engineering Drug Production by Type (2015-2020)
Table Global Genetic Engineering Drug Production Share by Type (2015-2020)
Figure Global Genetic Engineering Drug Production Share by Type (2015-2020)
Figure Global Genetic Engineering Drug Value ($) and Growth Rate of Monoclonal Antibody (2015-2020)
Figure Global Genetic Engineering Drug Value ($) and Growth Rate of Recombinant Human Erythropoietin (2015-2020)
Figure Global Genetic Engineering Drug Value ($) and Growth Rate of Recombinant Human Interferon (2015-2020)
Figure Global Genetic Engineering Drug Value ($) and Growth Rate of Recombinant Human Growth Hormone (2015-2020)
Figure Global Genetic Engineering Drug Value ($) and Growth Rate of Recombinant Human Insulin (2015-2020)
Figure Global Genetic Engineering Drug Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Genetic Engineering Drug Consumption by Application (2015-2020)
Table Global Genetic Engineering Drug Consumption Market Share by Application (2015-2020)
Figure Global Genetic Engineering Drug Consumption Market Share by Application (2015-2020)
Figure Global Genetic Engineering Drug Consumption and Growth Rate of ＜30 Years Old (2015-2020)
Figure Global Genetic Engineering Drug Consumption and Growth Rate of 30 Years Old-60 Years Old (2015-2020)
Figure Global Genetic Engineering Drug Consumption and Growth Rate of ＞60 Years Old (2015-2020)
Figure Global Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Global Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table Global Genetic Engineering Drug Sales by Regions (2015-2020)
Table Global Genetic Engineering Drug Sales Market Share by Regions (2015-2020)
Table Global Genetic Engineering Drug Revenue (M USD) by Regions (2015-2020)
Table Global Genetic Engineering Drug Revenue Market Share by Regions (2015-2020)
Table Global Genetic Engineering Drug Revenue Market Share by Regions in 2015
Table Global Genetic Engineering Drug Revenue Market Share by Regions in 2019
Figure North America Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Europe Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure South America Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table North America Genetic Engineering Drug Sales by Countries (2015-2020)
Table North America Genetic Engineering Drug Sales Market Share by Countries (2015-2020)
Table North America Genetic Engineering Drug Revenue (M USD) by Countries (2015-2020)
Table North America Genetic Engineering Drug Revenue Market Share by Countries (2015-2020)
Figure United States Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Canada Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Mexico Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table Europe Genetic Engineering Drug Sales by Countries (2015-2020)
Table Europe Genetic Engineering Drug Sales Market Share by Countries (2015-2020)
Table Europe Genetic Engineering Drug Revenue (M USD) by Countries (2015-2020)
Table Europe Genetic Engineering Drug Revenue Market Share by Countries (2015-2020)
Figure Germany Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure UK Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure France Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Italy Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Spain Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Russia Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Genetic Engineering Drug Sales by Countries (2015-2020)
Table Asia Pacific Genetic Engineering Drug Sales Market Share by Countries (2015-2020)
Table Asia Pacific Genetic Engineering Drug Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Genetic Engineering Drug Revenue Market Share by Countries (2015-2020)
Figure China Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Japan Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure South Korea Genetic Engineering Drug Sales and Growth (2015-2020)
Figure India Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Southeast Asia Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Australia Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Middle East Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table Middle East Genetic Engineering Drug Sales by Countries (2015-2020)
Table Middle East and Africa Genetic Engineering Drug Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Genetic Engineering Drug Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Genetic Engineering Drug Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure UAE Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Egypt Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Nigeria Genetic Engineering Drug Sales and Growth (2015-2020)
Figure South Africa Genetic Engineering Drug Sales and Growth (2015-2020)
Figure South America Genetic Engineering Drug Revenue (M USD) and Growth (2015-2020)
Table South America Genetic Engineering Drug Sales by Countries (2015-2020)
Table South America Genetic Engineering Drug Sales Market Share by Countries (2015-2020)
Table South America Genetic Engineering Drug Revenue (M USD) by Countries (2015-2020)
Table South America Genetic Engineering Drug Revenue Market Share by Countries (2015-2020)
Figure Brazil Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Argentina Genetic Engineering Drug Sales and Growth Rate (2015-2020)
Figure Columbia Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Chile Genetic Engineering Drug Sales and Growth (2015-2020)
Figure Top 3 Market Share of Genetic Engineering Drug Companies in 2019
Figure Top 6 Market Share of Genetic Engineering Drug Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Tonghua Dongbao Pharmaceutical Co., Ltd Profile
Table Tonghua Dongbao Pharmaceutical Co., Ltd Product Introduction
Figure Tonghua Dongbao Pharmaceutical Co., Ltd Production and Growth Rate
Figure Tonghua Dongbao Pharmaceutical Co., Ltd Value ($) Market Share 2015-2020
Table Beijing SL Pharmaceutical Co., Ltd Profile
Table Beijing SL Pharmaceutical Co., Ltd Product Introduction
Figure Beijing SL Pharmaceutical Co., Ltd Production and Growth Rate
Figure Beijing SL Pharmaceutical Co., Ltd Value ($) Market Share 2015-2020
Table Anhui Anke Biotechnology (Group) Co., Ltd Profile
Table Anhui Anke Biotechnology (Group) Co., Ltd Product Introduction
Figure Anhui Anke Biotechnology (Group) Co., Ltd Production and Growth Rate
Figure Anhui Anke Biotechnology (Group) Co., Ltd Value ($) Market Share 2015-2020
Table Jiangsu Sihuan Bioengineering Co., Ltd Profile
Table Jiangsu Sihuan Bioengineering Co., Ltd Product Introduction
Figure Jiangsu Sihuan Bioengineering Co., Ltd Production and Growth Rate
Figure Jiangsu Sihuan Bioengineering Co., Ltd Value ($) Market Share 2015-2020
Table Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Profile
Table Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Product Introduction
Figure Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Production and Growth Rate
Figure Shanghai Lansheng Guojian Pharmaceutical Co., Ltd Value ($) Market Share 2015-2020
Table 3SBio Inc. Profile
Table 3SBio Inc. Product Introduction
Figure 3SBio Inc. Production and Growth Rate
Figure 3SBio Inc. Value ($) Market Share 2015-2020
Table GeneScience Pharmaceuticals Co., Ltd Profile
Table GeneScience Pharmaceuticals Co., Ltd Product Introduction
Figure GeneScience Pharmaceuticals Co., Ltd Production and Growth Rate
Figure GeneScience Pharmaceuticals Co., Ltd Value ($) Market Share 2015-2020
Table Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Profile
Table Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Product Introduction
Figure Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Production and Growth Rate
Figure Shenzhen Neptunus Interlong Bio-Technique Co., Ltd Value ($) Market Share 2015-2020
Table Biotech Pharmaceutical Co., Ltd Profile
Table Biotech Pharmaceutical Co., Ltd Product Introduction
Figure Biotech Pharmaceutical Co., Ltd Production and Growth Rate
Figure Biotech Pharmaceutical Co., Ltd Value ($) Market Share 2015-2020
Table Market Driving Factors of Genetic Engineering Drug
Table Merger, Acquisition and New Investment
Table Global Genetic Engineering Drug Market Value ($) Forecast, by Type
Table Global Genetic Engineering Drug Market Volume Forecast, by Type
Figure Global Genetic Engineering Drug Market Value ($) and Growth Rate Forecast of Monoclonal Antibody (2020-2025)
Figure Global Genetic Engineering Drug Market Volume ($) and Growth Rate Forecast of Monoclonal Antibody (2020-2025)
Figure Global Genetic Engineering Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Erythropoietin (2020-2025)
Figure Global Genetic Engineering Drug Market Volume ($) and Growth Rate Forecast of Recombinant Human Erythropoietin (2020-2025)
Figure Global Genetic Engineering Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Interferon (2020-2025)
Figure Global Genetic Engineering Drug Market Volume ($) and Growth Rate Forecast of Recombinant Human Interferon (2020-2025)
Figure Global Genetic Engineering Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Growth Hormone (2020-2025)
Figure Global Genetic Engineering Drug Market Volume ($) and Growth Rate Forecast of Recombinant Human Growth Hormone (2020-2025)
Figure Global Genetic Engineering Drug Market Value ($) and Growth Rate Forecast of Recombinant Human Insulin (2020-2025)
Figure Global Genetic Engineering Drug Market Volume ($) and Growth Rate Forecast of Recombinant Human Insulin (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of ＜30 Years Old (2020-2025)
Figure Market Volume and Growth Rate Forecast of ＜30 Years Old (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of 30 Years Old-60 Years Old (2020-2025)
Figure Market Volume and Growth Rate Forecast of 30 Years Old-60 Years Old (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of ＞60 Years Old (2020-2025)
Figure Market Volume and Growth Rate Forecast of ＞60 Years Old (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
